RUNX1 and acute myeloid leukemia: Some mutations, such as DNMT3A, TET2, RUNX1, and EZH2, are suggested to have originated in HSCs, based on observations that these mutations have been detected in T-cells in patients with AML, which was called “lympho-myeloid clonal hematopoiesis” [45,46].